Corcept Therapeutics Inc (CORT): Share Repurchases
$172.91M
Year ended 2025-12-31
$42.46M
Trailing 12 months to 2026-06-30
+77.0%
5-year compound annual growth
| Period ended | Share Repurchases | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $172.91M | n/m | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $15.66M | n/a | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $0 | n/a | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $0 | n/a | 2025-02-26, From 2022-01-01 |
| No annual figure between 2020-12-31 and 2022-12-31. | |||
| 2020-12-31 | $9.95M | -67.9% | 2021-02-23, From 2020-01-01 |
| 2019-12-31 | $30.98M | +30.9% | 2021-02-23, From 2019-01-01 |
| 2018-12-31 | $23.66M | n/a | 2021-02-23, From 2018-01-01 |
| 2017-12-31 | $0 | n/a | 2020-02-24, From 2017-01-01 |
| 2016-12-31 | $0 | n/a | 2019-02-26, From 2016-01-01 |
Share Repurchases at similar companies
| Company | Year ended | Share Repurchases | Change YoY |
|---|---|---|---|
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $172.91M | n/m |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $24.90M | n/a |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $25.10M | -58.2% |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $148.33M | +493.3% |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $75.59M | -11.6% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $12.21M | +11.4% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $47.04M | -47.9% |
| Organogenesis Holdings Inc. (ORGO) | 2024-12-31 | $25.48M | n/a |
| HUTCHMED (China) Ltd (HCM) | 2024-12-31 | $36.06M | +297.6% |
Compare CORT, EBS, COLL, PCRX side by side · Screen every company in Pharmaceutical Preparations ↗